Cumberland Pharmaceuticals Raises $85 Million In IPO
This article was originally published in The Pink Sheet Daily
Executive Summary
First public offering for the pharmaceutical sector in 21 months suggests a financial thaw, but unlikely to spark an additional flood of deals.